Valerie Morisset
Founder en ELIEM THERAPEUTICS, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Valerie Morisset is the founder of Eliem Therapeutics, Inc., which was founded in 2018.
She currently holds the position of Chief Scientific Officer, EVP & Head-R&D at Eliem Therapeutics, Inc. Dr. Morisset is also the founder of Eliem Therapeutics (UK) Ltd.
and Convergence Pharmaceuticals Ltd.
She currently serves as a Director at Eliem Therapeutics (UK) Ltd.
and as Vice President & Head-Biology at Convergence Pharmaceuticals Ltd.
Dr. Morisset previously worked at GlaxoSmithKline LLC as a Principal.
She obtained her graduate degree from Université de Bordeaux.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ELIEM THERAPEUTICS, INC.
1.83% | 05/04/2024 | 505 307 ( 1.83% ) | 1 M $ | 31/03/2024 |
Cargos activos de Valerie Morisset
| Empresas | Cargo | Inicio |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Founder | 18/10/2018 |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Eliem Therapeutics (UK) Ltd.
 Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Founded in 2019, Eliem Therapeutics (UK) Ltd. is a British company that engages in research and development on biotechnology. Part of Eliem Therapeutics, Inc., the private company is based in Altrincham, UK. | Director/Board Member | 18/12/2019 |
Antiguos cargos conocidos de Valerie Morisset.
| Empresas | Cargo | Fin |
|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Formación de Valerie Morisset.
| Université de Bordeaux | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Convergence Pharmaceuticals Ltd.
Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Eliem Therapeutics (UK) Ltd.
Eliem Therapeutics (UK) Ltd. BiotechnologyHealth Technology Founded in 2019, Eliem Therapeutics (UK) Ltd. is a British company that engages in research and development on biotechnology. Part of Eliem Therapeutics, Inc., the private company is based in Altrincham, UK. | Health Technology |
- Bolsa de valores
- Insiders
- Valerie Morisset
